TMates Weightloss Semaglutide

TMates Weightloss Semaglutide TMates is an online weight‑loss platform offering a telemedicine‑based program using GLP‑1 medications like semaglutide and tirzepatide. Over 40,000 individuals have participated. The program offers both oral and injectable options, all delivered by prescription, without hidden fees, insurance barriers, or waitlists. Semaglutide is a GLP‑1 receptor agonist—a synthetic version of a hormone your gut releases after eating. Available in injectable and oral forms, it was originally approved for type 2 diabetes treatment but now has FDA-approved versions (e.g., Wegovy) specifically for weight management in individuals with obesity or overweight with comorbidities.